Literature DB >> 26143628

Sphincter of Oddi Dysfunction: Updates from the Recent Literature.

Mohammad Yaghoobi1, Joseph Romagnuolo.   

Abstract

Sphincter of Oddi dysfunction (SOD) has long been a controversial topic, starting with whether it even exists, as a sphincterotomy-responsive entity to treat, for either: (1) post-cholecystectomy abdominal pain and/or (2) idiopathic recurrent acute pancreatitis (IRAP). Many of its aspects had required further research to better prove or refute its existence and to provide proper recommendations for physicians to diagnose and treat this condition. Fortunately, there has been major advancement in our knowledge in several areas over the past few years. New studies on challenging the classification, exploring alternative diagnostic methods, and quantifying the role of sphincterotomy in treatment of SOD for post-cholecystectomy pain and for IRAP were recently published, including a randomized trial in each of the two areas. The goal of this paper is to review recent literature on selected important questions and to summarize the results of major trials in this field.

Entities:  

Mesh:

Year:  2015        PMID: 26143628     DOI: 10.1007/s11894-015-0455-z

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  33 in total

1.  Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction.

Authors:  Martin L Freeman; Muzaffar Gill; Carol Overby; Ye-Ying Cen
Journal:  J Clin Gastroenterol       Date:  2007-01       Impact factor: 3.062

2.  Impact of pancreatic stent caliber on post-endoscopic retrograde cholangiopancreatogram pancreatitis rates in patients with confirmed sphincter of Oddi dysfunction.

Authors:  Jayapal Ramesh; Hwasoon Kim; Kartika Reddy; Shyam Varadarajulu; C Mel Wilcox
Journal:  J Gastroenterol Hepatol       Date:  2014       Impact factor: 4.029

3.  Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction.

Authors:  Valerie Durkalski; Walter Stewart; Paulette MacDougall; Patrick Mauldin; Joseph Romagnuolo; Olga Brawman-Minzter; Peter Cotton
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

4.  Long-term results (≥ 10 years) of endoscopic therapy for sphincter of Oddi dysfunction in patients with acute recurrent pancreatitis.

Authors:  T Wehrmann
Journal:  Endoscopy       Date:  2010-11-24       Impact factor: 10.093

5.  A new distensibility technique to measure sphincter of Oddi function.

Authors:  P Kunwald; A M Drewes; D Kjaer; F H Gravesen; B P McMahon; L Madácsy; P Funch-Jensen; H Gregersen
Journal:  Neurogastroenterol Motil       Date:  2010-06-14       Impact factor: 3.598

6.  Botulinum toxin-induced relaxation of the sphincter of Oddi may select patients with acalculous biliary pain who will benefit from cholecystectomy.

Authors:  William R Murray
Journal:  Surg Endosc       Date:  2010-07-28       Impact factor: 4.584

7.  Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry.

Authors:  Evangelos Kalaitzakis; Tim Ambrose; Jane Phillips-Hughes; Jane Collier; Roger W Chapman
Journal:  BMC Gastroenterol       Date:  2010-10-22       Impact factor: 3.067

8.  Investigation of Oddi sphincter structure by optical coherence tomography in patients with biliary-type 1 dysfunction: a pilot in vivo study.

Authors:  P A Testoni; B Mangiavillano; A Mariani; S Carrara; C Notaristefano; P G Arcidiacono
Journal:  Dig Liver Dis       Date:  2009-04-28       Impact factor: 4.088

9.  Intraluminal pressure recording from the human sphincter of Oddi.

Authors:  J E Geenen; W J Hogan; W J Dodds; E T Stewart; R C Arndorfer
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

10.  Determination of sphincter of Oddi dysfunction in patients with prior normal manometry.

Authors:  Shyam Varadarajulu; Robert H Hawes; Peter B Cotton
Journal:  Gastrointest Endosc       Date:  2003-09       Impact factor: 9.427

View more
  2 in total

1.  How to apply clinical cases and medical literature in the framework of a modified "failure mode and effects analysis" as a clinical reasoning tool--an illustration using the human biliary system.

Authors:  Kam Cheong Wong
Journal:  J Med Case Rep       Date:  2016-04-06

2.  Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.

Authors:  Brooks D Cash; Brian E Lacy; Philip S Schoenfeld; Leonard S Dove; Paul S Covington
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.